Home/PMV Pharmaceuticals/Andreas G. Bader, Ph.D.
AG

Andreas G. Bader, Ph.D.

Chief Scientific Officer

PMV Pharmaceuticals

PMV Pharmaceuticals Pipeline

DrugIndicationPhase
PC14586 (revetrectinib)Advanced solid tumors with p53 Y220C mutationPhase 1/2